Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT01081145 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-deficit/Hyperactivity Disorder

Interventions

DRUG: Extended-release Guanfacine Hydrochloride
OTHER: Placebo

Sponsor

Shire